Get my own profile
Public access
View all90 articles
9 articles
available
not available
Based on funding mandates
Co-authors
Nitash P. BalsaraUniversity of California, Berkeley, and Lawrence Berkeley National LaboratoryVerified email at berkeley.edu
Kent KirshenbaumProfessor of Chemistry, New York UniversityVerified email at nyu.edu
Rachel SegalmanEdward Noble Kramer Professor of Materials, UCSBVerified email at ucsb.edu
Ken A. DillDirector of Laufer Center, Stony Brook UniversityVerified email at laufercenter.org
F E CohenUCSFVerified email at pacbell.net
Walter H MoosUCSF, Pandect Bioventures, ShangPharma Innovation, SRI, MitoKor, Chiron, Warner-Lambert/Parke-DavisVerified email at ucsf.edu
Sunting XuanSoochow UniversityVerified email at suda.edu.cn
Xi JiangLawrence Berkeley National LaboratoryVerified email at lbl.gov
David PrendergastMolecular Foundry, Lawrence Berkeley National LaboratoryVerified email at lbl.gov
Eric J. MartinNovartisVerified email at novartis.com
Ryan K SpencerProtomer Technologies, a wholly-owned subsidiary of Eli Lilly and companyVerified email at uci.edu
Stephen WhitelamStaff Scientist, Lawrence Berkeley National LabVerified email at lbl.gov
Caroline ProulxNorth Carolina State UniversityVerified email at ncsu.edu
Helen TranUniversity of TorontoVerified email at utoronto.ca
Glenn ButterfossProteinQureVerified email at proteinqure.com
Babak SaniiNutcracker TherapeuticsVerified email at nutcrackerx.com
Adrianne RosalesAssociate Professor, University of Texas at AustinVerified email at che.utexas.edu
Ranjan MannigeCerevel TherapeuticsVerified email at lbl.gov
Ki Tae NamProfessor, Department of Materials Science and Engineering, Seoul National UniversityVerified email at snu.ac.kr
Deborah CharychNektar TherapeuticsVerified email at nektar.com
Follow![Ronald N. Zuckermann](https://usercontent.cljtscd.com/citations?view_op=view_photo&user=eHfqZYUAAAAJ&citpid=2)
Ronald N. Zuckermann
Molecular Foundry, Lawrence Berkeley National Laboratory
Verified email at lbl.gov - Homepage